November 14, 2022 – Illuminate, Inc., the software provider that unlocks vital unstructured clinical information lost in the EHR that can improve patient care, announces its end-to-end tracking and monitoring solution called Discovery360 Services. They are designed to simplify a healthcare facility’s ability to implement a multidisciplinary pulmonary nodule surveillance program.
Our Discovery 360 services combine the skills of our nurse navigators with our understanding of the patient monitoring and management process and Illuminate ActKnowledge AI technology. Together, we can reduce the barriers to implementing a comprehensive lung nodule surveillance program that saves lives by ensuring patients receive timely diagnosis and treatment.
- Better patient outcomes
- Additional imaging and surgery income
- Increased productivity of physicians and pivot nurses
- Fewer patients lost to follow-up care
Illuminate ActKnowledge, along with the full suite of Illuminate apps will be available for demonstration at the Illuminate booth at the Radiological Society of North America (RSNA) annual meeting this month. Visit Illuminate at RSNA at Booth #6711 – North Hall.
Illuminate will also discuss the value of an enterprise approach to solving the follow-up management problem in its RSNA Innovation Theater presentation.
Title: Tracking Incidental Findings Leading to Action; It’s not enough to follow them
When: Tuesday, November 29, 2:30 p.m.
Where: Theater of Innovation, Booth 3316 – South Hall
Registered RSNA attendees can add the presentation to their schedule by clicking here.
“80% of patients with lung nodules are identified incidentally by radiology, NOT lung screening,” notes Dr. Mark Perry, MD, radiologist, imaging oncology, “AI-supported services like Discovery 360 enable to radiology to ensure that patients receive timely follow-up. care they need while minimizing the operational load.
Illuminate ActKnowledge provides the foundation for a comprehensive pulmonary nodule program by simplifying and automating the identification and management of these patients, whether they are identified as an incidental finding by radiology or via a pulmonary screening program. It uses AI to automate the inefficient manual process of patient identification, tracking, and reporting, enabling healthcare providers to improve resource utilization, patient care, and service management .
“Radiology has always been held accountable for ensuring that follow-up imaging is performed and its recommendations are received by the treating physician,” says Matt McLenon, CEO. “This is only the tip of the follow-up iceberg, as comprehensive follow-up requires coordinated ongoing imaging, patient monitoring, and treatment.”
Other Illuminate apps that will be available for demonstration at RSNA include:
- InSight – Research-driven access to any clinical report.
- PatientView – Instant access to the complete patient record at the point of care.
- Analytics – Factual monitoring of resource planning and allocation.
For more information: https://www.illuminate.ai/
Find more RSNA22 coverage here